- Home
- C vs MDT Comparison
C vs MDT Comparison
Compare C & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- C
- MDT
- Stock Information
- Founded
- C 1812
- MDT 1949
- Country
- C United States
- MDT Ireland
- Employees
- C N/A
- MDT N/A
- Industry
- C Major Banks
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- C Finance
- MDT Health Care
- Exchange
- C Nasdaq
- MDT Nasdaq
- Market Cap
- C 132.9B
- MDT 109.2B
- IPO Year
- C N/A
- MDT N/A
- Fundamental
- Price
- C $75.48
- MDT $81.21
- Analyst Decision
- C Buy
- MDT Hold
- Analyst Count
- C 14
- MDT 16
- Target Price
- C $86.32
- MDT $94.73
- AVG Volume (30 Days)
- C 11.8M
- MDT 7.5M
- Earning Date
- C 07-11-2025
- MDT 05-21-2025
- Dividend Yield
- C 2.97%
- MDT 3.50%
- EPS Growth
- C 85.23
- MDT 30.80
- EPS
- C 6.33
- MDT 3.61
- Revenue
- C $71,819,000,000.00
- MDT $33,537,000,000.00
- Revenue This Year
- C $19.70
- MDT $5.38
- Revenue Next Year
- C $3.01
- MDT $5.08
- P/E Ratio
- C $11.93
- MDT $22.48
- Revenue Growth
- C 3.25
- MDT 3.62
- 52 Week Low
- C $53.51
- MDT $75.96
- 52 Week High
- C $84.74
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- C 62.53
- MDT 39.02
- Support Level
- C $71.65
- MDT $79.93
- Resistance Level
- C $76.32
- MDT $88.28
- Average True Range (ATR)
- C 1.32
- MDT 1.55
- MACD
- C -0.02
- MDT -0.34
- Stochastic Oscillator
- C 87.41
- MDT 15.33
About C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.